Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 2/2020

01-02-2020 | Metastasis | Original Article – Clinical Oncology

Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation

Authors: Yinping Dong, Yiran Qiu, Jingyu Deng, Wei Wang, Zhe Sun, Zhenning Wang, Zhiwei Zhou, Huimian Xu, Han Liang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 2/2020

Login to get access

Abstract

Purpose

The present study aims to validate possible stage migration of lymph node metastasis related to the insufficient examined lymph node (ELN) count in pN3a gastric cancer (GC) patients.

Methods

1976 pN3 patients who underwent the R0 surgery in three high-capacity institutions in China were enrolled to explore the stage migration of nodal involvement, and 3146 pN3 cases from the Surveillance, Epidemiology, and End Results (SEER) Program Registry were used as an external validation cohort.

Results

After the propensity score matching of the Chinese cohort, the ELN count, as an independent predictor for GC outcome, was confirmed to be associated with the stage migration of lymph node metastasis in pN3a patients based on the univariate and multivariate survival analyses. Logistic regress was adopted to elucidate that the ELN count was an independent factor related to the long-term survival status of GC patients after curative surgery. Likelihood ratio test showed that the ELN count had the smallest Bayesian information criterion value among the clinicopathologic variables, corresponding to an efficient model to predict outcomes. Subsequently, stage migration of lymph node metastasis was predominantly detected in pN3a patient sub-group with insufficient (less than 16) ELN count, who presented with similar prognosis as the pN3b patients (P = 0.463) as per the stratum analysis with Kaplan–Meier. These methods were further validated using data from the SEER cohort, and the similar promising results were obtained.

Conclusion

pN3a patients with insufficient ELN count should be considered as pN3b cases to achieve accurate prognostic evaluation after curative gastrectomy.
Appendix
Available only for authorised users
Literature
go back to reference Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, New York Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, New York
go back to reference Coburn NG, Swallow CJ, Kiss A et al (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151CrossRef Coburn NG, Swallow CJ, Kiss A et al (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151CrossRef
go back to reference Deng J, Liang H, Sun D et al (2008) Prognosis of gastric cancer patients with negative node metastasis following curative resection. Outcomes of the survival and recurrence. Can J Gastroenterol 22:835–839CrossRef Deng J, Liang H, Sun D et al (2008) Prognosis of gastric cancer patients with negative node metastasis following curative resection. Outcomes of the survival and recurrence. Can J Gastroenterol 22:835–839CrossRef
go back to reference Deng JY, Liang H, Sun D et al (2009) Outcome in relation to numbers of nodes harvested in lymph node positive gastric cancer. Eur J Surg Oncol 35:814–819CrossRef Deng JY, Liang H, Sun D et al (2009) Outcome in relation to numbers of nodes harvested in lymph node positive gastric cancer. Eur J Surg Oncol 35:814–819CrossRef
go back to reference Deng J, Zhang R, Pan Y et al (2014a) Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the TNM classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery 156:64–74CrossRef Deng J, Zhang R, Pan Y et al (2014a) Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the TNM classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery 156:64–74CrossRef
go back to reference Deng J, Liang H, Ying G et al (2014b) Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. J Am Coll Surg 219:904–913CrossRef Deng J, Liang H, Ying G et al (2014b) Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. J Am Coll Surg 219:904–913CrossRef
go back to reference Deng J, Yamashita H, Seto Y et al (2017) Increasing the number of examined lymph nodes is prerequisite for improvement accurate evaluation the overall survival of node-negative gastric cancer patients. Ann Surg Oncol 24:745–753CrossRef Deng J, Yamashita H, Seto Y et al (2017) Increasing the number of examined lymph nodes is prerequisite for improvement accurate evaluation the overall survival of node-negative gastric cancer patients. Ann Surg Oncol 24:745–753CrossRef
go back to reference Deng J, Liu J, Wang W et al (2018) Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chin J Cancer Res 30:477–491CrossRef Deng J, Liu J, Wang W et al (2018) Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chin J Cancer Res 30:477–491CrossRef
go back to reference Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608CrossRef Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608CrossRef
go back to reference Hayashi S, Kanda M, Ito S et al (2019) Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 22:853–863CrossRef Hayashi S, Kanda M, Ito S et al (2019) Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 22:853–863CrossRef
go back to reference In H, Solsky I, Palis B et al (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24:3683–3691CrossRef In H, Solsky I, Palis B et al (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24:3683–3691CrossRef
go back to reference Jaehne J, Meyer HJ, Maschek H et al (1992) Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg 127:290–294CrossRef Jaehne J, Meyer HJ, Maschek H et al (1992) Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg 127:290–294CrossRef
go back to reference Jiao XG, Deng JY, Zhang RP et al (2014) Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 20:3640–3648CrossRef Jiao XG, Deng JY, Zhang RP et al (2014) Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 20:3640–3648CrossRef
go back to reference Liu YY, Fang WL, Wang F et al (2017) Does a higher cutoff value of lymph node retrieval substantially improve survival in patients with advanced gastric cancer?—Time to embrace a new digit. Oncologist 22:97–106CrossRef Liu YY, Fang WL, Wang F et al (2017) Does a higher cutoff value of lymph node retrieval substantially improve survival in patients with advanced gastric cancer?—Time to embrace a new digit. Oncologist 22:97–106CrossRef
go back to reference Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef
go back to reference Sano T, Coit DG, Kim HH et al (2017) Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 20:217–225CrossRef Sano T, Coit DG, Kim HH et al (2017) Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 20:217–225CrossRef
go back to reference Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York
Metadata
Title
Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation
Authors
Yinping Dong
Yiran Qiu
Jingyu Deng
Wei Wang
Zhe Sun
Zhenning Wang
Zhiwei Zhou
Huimian Xu
Han Liang
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 2/2020
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-03081-0

Other articles of this Issue 2/2020

Journal of Cancer Research and Clinical Oncology 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.